In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Crina Elena TironTRANSCEND Centre, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483 Iasi, Romania.ORCID 0000-0002-1469-9153 Gabriel LutaTRANSCEND Centre, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483 Iasi, Romania.
Razvan GhiarasimCentre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-6540-9163 Adrian TironTRANSCEND Centre, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483 Iasi, Romania.ORCID 0000-0002-7006-5884 Valentin NastasaTranslational Research Center for Antimicrobial and Anticancer Agents, Iasi, Faculty of Veterinary Medicine, University of life Sciences, 8 Aleea Mihail Sadoveanu, 700489 Iasi, Romania.ORCID 0000-0001-7384-8692 Dragos Constantin AnitaTranslational Research Center for Antimicrobial and Anticancer Agents, Iasi, Faculty of Veterinary Medicine, University of life Sciences, 8 Aleea Mihail Sadoveanu, 700489 Iasi, Romania.ORCID 0000-0001-5463-6651 Tore Geir IversenDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
Tore SkotlandDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
Kirsten SandvigDepartment of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.ORCID 0000-0002-4174-9072 Mihai MaresTranslational Research Center for Antimicrobial and Anticancer Agents, Iasi, Faculty of Veterinary Medicine, University of life Sciences, 8 Aleea Mihail Sadoveanu, 700489 Iasi, Romania.ORCID 0000-0002-3103-4954 Mihail-Gabriel DimofteTRANSCEND Centre, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483 Iasi, Romania.
Funding
EEA Grants 37/2021
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
drug delivery systemEMTtargeted deliveryTNBCtrastuzumab
Identifiers
PMID41471069
PMCPMC12736354
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390